The Journal of Rheumatology

 

The Journal of Rheumatology
A

HCQ-Induced Hyperpigmentation in Lupus Patients: What Are the HCQ Side Effects? Are They Dose/Duration Dependent?

By The Journal of Rheumatology FEATURING Amir Bajoghli
By The Journal of Rheumatology FEATURING Amir Bajoghli
8 views
February 18, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

09:07
GSK

Identifying Eosinophilic Granulomatosis With Polyangiitis and Hypere…

Feat. M. O'Connor
Videos
16:19
The Journal of Rheumatology

Patient and Physician Perspectives of Systemic Lupus Erythematosus F…

Feat. J. Rogers, A. Eudy, E. Silverman
13:56
The Journal of Rheumatology

PROs & Remission Rates in Patients With PsA Treated With TNFi

Feat. L. M. Ørnbjerg, E. Silverman
11:34
The Journal of Rheumatology

Plasma Cartilage Acidic Protein 1 Measured by ELISA Is Associated Wi…

Feat. R. D. Chapurlat, E. Silverman
19:58
The Journal of Rheumatology

The Problem of Pain in Rheumatology: Variations in Case Definitions …

Feat. T. Falasinnu, E. Silverman
18:55
The Journal of Rheumatology

Measuring What Matters: A Qualitative Study of the Relevance and Cli…

Feat. S. Kasturi, E. Silverman
16:34
The Journal of Rheumatology

Obesity Represents a Persisting Health Issue in Axial Spondyloarthri…

Feat. R. Micheroli, E. Silverman
06:31
The Journal of Rheumatology

Long-Term Prognosis of Antimelanoma Differentiation–Associated Gene …

Feat. T. Sasai
08:19
The Journal of Rheumatology

Renal Histopathology Associated With Kidney Failure & Mortality …

Feat. Y. Liao
06:11
The Journal of Rheumatology

Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associa…

Feat. S. Moiseev
29:21
The Journal of Rheumatology

PROMIS Measures in a Treat-to-Target Approach to Treatment of RA

Feat. G. J. Greene, D. Cella, E. Ruderman, E. Silverman
18:44
The Journal of Rheumatology

Editor's Picks Spotlight: Why Do Patients With Gout Not Take Al…

Feat. E. Silverman, Y. Emad, K. J. Petrie
04:09
The Journal of Rheumatology

Video Abstract: Gout Flare in Patients Hospitalized for PCR-Confirme…

Feat. K. Jatuwarapuk
07:07
The Journal of Rheumatology

Central Obesity in Axial Spondyloarthritis: The Missing Link to Unde…

Feat. S. Maguire
05:49
The Journal of Rheumatology

Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselk…

Feat. P. Rahman
21:14
The Journal of Rheumatology

Outcomes of Care Among Patients With Gout in Europe: A Cross-section…

Feat. E. Silverman, A. Boonen
07:17
The Journal of Rheumatology

2-Year Structural Progression IXE in Patients Receiving Ixekizumab

Feat. W. P. Maksymowych
22:39
The Journal of Rheumatology

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

Feat. E. Silverman, J. Rosenbaum, J. Reveille, K. Winthrop
05:35
The Journal of Rheumatology

Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection…

Feat. J. Curtis
08:54
The Journal of Rheumatology

Impact of Comorbid Conditions on Healthcare Expenditure and Work-Rel…

Feat. A. Tran-Duy
14:37
The Journal of Rheumatology

The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know …

Feat. E. Silverman, J. B. Galloway
05:06
The Journal of Rheumatology

Impact of the Season of Birth on the Development of Juvenile Idiopat…

Feat. S. Prahalad
10:20
The Journal of Rheumatology

Hospitalization Rates Are Highest in the First 5 Years of Systemic S…

Feat. A. Makol
07:00
The Journal of Rheumatology

Comparison of Men and Women With Axial Spondyloarthritis in the US-B…

Feat. P. Mease
06:21
The Journal of Rheumatology

Axial Involvement in Psoriatic Arthritis: Effect on Peripheral Arthr…

Feat. R. García Salinas
05:16
The Journal of Rheumatology

Improved Incidence of Cardiovascular Disease in Patients With Incide…

Feat. E. Myasoedova
02:55
The Journal of Rheumatology

Evaluation of Bone Erosions in RA: The Ultrasound Score for Erosions…

Feat. J. Grosse
02:46
The Journal of Rheumatology

Esophageal Obstruction Secondary to Massive Tumoral Calcinosis: Pati…

Feat. J. An
05:42
The Journal of Rheumatology

Effect on Costs and Quality-Adjusted Life-Years of Treat-To-Target T…

Feat. M. Verhoeven
05:44
The Journal of Rheumatology

When Has a Knee or Hip Replacement Failed? A Patient Perspective - S…

Feat. J. Singh
10:16
The Journal of Rheumatology

CanVasc Consensus Recommendations for the Management of ANCA-Associa…

Feat. A. Mendel
05:07
The Journal of Rheumatology

The Inverse OARSI-OMERACT Is a Valid Indicator of the Clinical Worse…

Feat. J. B. Driban
06:11
The Journal of Rheumatology

Pediatric to Adult Rheumatology Care Transitions in Canada: What Are…

Feat. C. Barnabe
16:14
The Journal of Rheumatology

Intramuscular Pressure Is Almost Three Times Higher in Fibromyalgia …

Feat. D. Robert Katz
09:29
The Journal of Rheumatology

Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Di…

Feat. A. Faye
05:56
The Journal of Rheumatology

Study Highlights on CVD Risk Scores in axSpA vs. General Population:…

Feat. J. Liew
04:50
The Journal of Rheumatology

Venous Thromboembolism in Systemic Sclerosis: Prevalence, Risk Facto…

Feat. S. R. Johnson
01:54
The Journal of Rheumatology

GCA Mortality Study Overview: Is GCA Associated With Increased Morta…

Feat. N. Ben-Shabat
01:35
The Journal of Rheumatology

Systemic Sclerosis-ILD Management: What Is the Safety/Efficacy of th…

Feat. E. R. Volkmann
06:01
The Journal of Rheumatology

Risk of Advanced LN: What Is the Effect of a Single APOL1 Gene Nephr…

Feat. G. Fernandes
04:14
The Journal of Rheumatology

Monophasic Disease Course in SLE: Prevalence and Characteristics

Feat. M. B. Urowitz
11:28
The Journal of Rheumatology

NET Profiles in Patients With Incident SLE & Lupus Nephritis: Ar…

Feat. G. Marco Ghiggeri
08:33
The Journal of Rheumatology

HCQ in Patients With Rheumatic Disease Complicated by COVID-19: Clar…

Feat. S. J. Balevic
02:15
The Journal of Rheumatology

Home Monitoring for RA Patients: Are Patient-Performed Assessments o…

Feat. M. Skougaard
04:36
The Journal of Rheumatology

RA Management: What Are the Effects of Sarilumab on RA as Reported b…

Feat. L. Gossec
07:06
The Journal of Rheumatology

Placebo Response in RA Clinical Trials: The Change in Placebo Respon…

Feat. J. B. Galloway
06:09
The Journal of Rheumatology

Characteristics of Accelerated Hand OA: What Is the Association Betw…

Feat. J. B. Driban
04:15
The Journal of Rheumatology

Metacarpophalangeal Joints Assessment in RA: How to Examine Metacarp…

Feat. E. Keystone
05:50
The Journal of Rheumatology

Diagnosis & Monitoring of Enthesitis in PsA: How to Examine the …

Feat. C. Bakewell
04:26
The Journal of Rheumatology

Association of HLA‐B27 With SARS‐CoV‐2: What Is the Effect of HLA‐B2…

Feat. J. Rosenbaum
05:26
The Journal of Rheumatology

axSpA Performance Index Test: What Is the Reliability and Feasibilit…

Feat. R. E. Van Bentum
03:13
The Journal of Rheumatology

Scleroderma Renal Crisis in SSc Reserach Overview: Analysis of Anti-…

Feat. C. P. Denton
02:45
The Journal of Rheumatology

What It Means to Me to Have Juvenile Arthritis: Patient's Defin…

Feat. A. Robertson
03:08
The Journal of Rheumatology

HCQ-Induced Hyperpigmentation in Lupus Patients: What Are the HCQ Si…

Feat. A. Bajoghli
03:08
The Journal of Rheumatology

AS Population-Based Data Linkage Study Highlights: What Is the Risk …

Feat. M. Ognjenovic
04:05
The Journal of Rheumatology

COVID-19 & RMDs: Concerns, Healthcare Use & Treatment Interr…

Feat. M. D. George